Evaluation and Management of Overactive Bladder

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2016 Fall Forum. If you participated in
the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2017 to December 31, 2017

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  To print or save your certificate, you will need to click on the “download” button and either print or save.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Astellas Scientific & Medical Affairs

Overactive bladder (OAB) is a highly prevalent condition that occurs about twice as frequently in women as in men, and while OAB is not considered a normal part of aging, it does become more prevalent with advanced age. OAB has a significant impact on quality of life (QoL), co-morbidities and cost; sufferers are two to three times more likely to experience disturbed sleep, overeating, poor self-esteem, and depression. Despite its impact, OAB remains underdiagnosed and undertreated thus screening and evaluating patients is of utmost importance in order to improve diagnosis and patient QoL. Fortunately there are a variety of treatments available from behavioral modification (drink less fluid, caffeine…etc.) to antimuscarinic agents and ß3-adrenoceptor agonists. There is a stepwise progression in the management of OAB and multiple options of treatment available in each of the lines of therapy provide for a tailored approach to individualize treatment based upon a patient’s expectation and goal for treatment, their co-morbidities, symptoms, and the side-effects of treatments.

Upon Completion of this activity, participants will be able to:

  • Compare and contrast the safety, efficacy and mechanisms of action of antimuscarinic agents and ß3-adrenoceptor agonists in overactive bladder (OAB) management

  • Individualize treatment for patients with OAB with an understanding of the differences among available therapies, impact of patient comorbidities and disease-related features, and treatment-emergent adverse events

  • Discuss effective patient engagement strategies and diagnostic tools for screening and assessing OAB

  • Describe the benefits and risks of currently recommended therapeutic approaches for the management of OAB, including behavioral interventions and pharmacologic options

  • Examine individualized strategies to manage treatment-emergent adverse events and therapy modification in order to improve patient adherence and outcomes

Faculty: Craig V. Comiter, MD
Professor of Urology, Obstetrics and Gynecology
Stanford University Medical Center
Urology Clinic


Dr. Comiter serves as a consultant to Axonics, Coloplast and Neuspera. His presentation has been peer reviewed.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The National Association of Managed Care Physicians designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity and turn in a validation form will receive up to 1 credit in continuing nursing education.

The American Board of Managed Care Nurses has approved this activity for a maximum of 1 contact hour towards CMCN recertification.

This activity is supported by an educational grant from
Astellas Scientific & Medical Affairs

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue